An RNA-editing gene therapy has been developed that switches off the key driv-er of common eye conditions affecting diabetics and the elderly. The researchers behind the innovative treatment say that it’s an alternative to the current treatment: regular injections of…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.